Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia
Key facts
- Who runs it
- University of Southern California
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Suspended
- People taking part
- 1,000 people, planned
- Started
- 1 May 2026
- Expected to end
- 30 Aug 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Risk Assessment Screening
- Coach and Website Intervention
- Record updated
- 24 February 2026
- Why it stopped
- Study paused per IRB request.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- 18 years old or older
- Speak English or Spanish
- Caregiver for a person with Alzheimer's Disease or another type of dementia
- Provide substantial care for this person, defined as assisting with at least one activity of daily living or two instrumental activities of daily living
- See this person at least twice a week
- Have access to the internet
Who cannot take part
- Caregiver for person who does not have dementia
- Primary relationship between caregiver and person with dementia is that of a professional paid caregiver
- Under 18 years old
- Speak language besides English or Spanish
- Do not provide substantial care for this person
- Enrolled in another caregiver study
Where in United States
- Keck MedicineLos Angeles, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are:
Read full original descriptionShow less
1. What are the harms and benefits of administering the elder abuse risk assessment screening? 2. What are the harms and benefits of administering the caregiver intervention?
Researchers will compare participants who receive the screening and caregiver intervention to a group who does not receive the caregiver intervention and a group who receives neither the screening or the caregiver intervention to answer these questions.
Participants will:
* Complete two surveys, three months apart * Complete a 5-item screening tool, if assigned to one of the screening groups * Complete a 3-session caregiver intervention, if assigned to that group
The 3 groups in the trial
- ControlNo study treatment, for comparison
Participants will receive no intervention, only the two study surveys.
- Risk Assessment Screening OnlyTreatment being tested
Participants will complete the risk assessment screening along with the two study surveys.
Treatment: Risk Assessment Screening
- Risk Assessment Screening and Coach InterventionTreatment being tested
Participants will complete the risk assessment screening, three coach sessions, intervention website, and the two study surveys.
Treatment: Risk Assessment Screening and Coach and Website Intervention
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 February 2026